Angiotensin II-induced increase in myocardial distensibility and its modulation by the endocardial endothelium in the rabbit heart

Experimental Physiology

Volumn 94, Issue 6, 2009, Pages 665-674

  Castro Chaves, Paulo ^a   Fontes Carvalho, Ricardo ^a   Pintalhao, Mariana ^a   Pimentel Nunes, Pedro ^a   Leite Moreira, Adelino F ^a  

^a University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; APOCYNIN; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; N(G) NITROARGININE; TRITON X 100;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; ENDOCARDIUM; ENDOTHELIUM; HEART; HEART MUSCLE COMPLIANCE; HEART PAPILLARY MUSCLE; INOTROPISM; MALE; MODULATION; MUSCLE LENGTH; MUSCLE TONE; NONHUMAN; RABBIT;

EID: 65649094804     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2008.046458     Document Type: Article

References (64)

1. Brás-Silva C Leite-Moreira AF (2006). Obligatory role of the endocardial endothelium in the increase of myocardial distensibility induced by endothelin-1. Exp Biol Med (Maywood) 231, 876 881. (Pubitemid 43845545)
2. Brás-Silva C, Monteiro-Sousa D, Duarte AJ, Guerra M, Fontes-Sousa AP, Moura C, Areias JC Leite Moreira AF (2008). Nitric oxide and prostaglandins - important players in endothelin-1 induced myocardial distensibility. Physiol Res 57, 165 174.
3. 2 receptor-deficient mice. Hypertension 42, 1177 1182. (Pubitemid 37549074)
4. Brutsaert DL (2003). Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83, 59 115. (Pubitemid 36459878)
5. Brutsaert DL, Meulemans AL, Sipido KR Sys SU (1988). Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res 62, 358 366. (Pubitemid 18041957)
6. Carey RM Siragy HM (2003). Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 24, 261 271. (Pubitemid 36733542)
7. A receptors and endothelium partially mediate the positive inotropic and lusitropic effects of angiotensin II. Eur J Pharmacol 544, 91 96. (Pubitemid 44148570)
8. 2 receptor stimulation and its modulation by the endocardial endothelium. Eur J Pharmacol 578, 261 269.
9. de Gasparo M, Catt KJ, Inagami T, Wright JW Unger T (2000). International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52, 415 472. (Pubitemid 32053073)
10. De Keulenaer GW, Andries LJ, Sys SU Brutsaert DL (1995). Endothelin-mediated positive inotropic effect induced by reactive oxygen species in isolated cardiac muscle. Circ Res 76, 878 884.
11. Dostal DE Baker KM (1999). The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function? Circ Res 85, 643 650. (Pubitemid 29467853)
12. Dzau VJ (1984). Vascular wall renin-angiotensin pathway in control of the circulation. A hypothesis. Am J Med 77, 31 36. (Pubitemid 15200189)
13. Dzau VJ (1988). Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 77, I4 13. (Pubitemid 18124626)
14. Dzau VJ Re RN (1987). Evidence for the existence of renin in the heart. Circulation 75, I134 I136. (Pubitemid 17009856)
15. Evans HG, Lewis MJ Shah AM (1994). Modulation of myocardial relaxation by basal release of endothelin from endocardial endothelium. Cardiovasc Res 28, 1694 1699. (Pubitemid 24344144)
16. Gillebert TC Raes DF (1994). Preload, length-tension relation, and isometric relaxation in cardiac muscle. Am J Physiol Heart Circ Physiol 267, H1872 H1879. (Pubitemid 2164403)
17. Gomez Llambi H, Manni F, La Padula P, Carretero OA Taquini CM (1996). Myocardial contractility is modulated by angiotensin II via nitric oxide. Hypertension 27, 704 708. (Pubitemid 26086235)
18. Herizi A, Jover B, Bouriquet N Mimran A (1998). Prevention of the cardiovascular and renal effects of angiotensin II by endothelin blockade. Hypertension 31, 10 14. (Pubitemid 28124684)
19. Heymes C, Vanderheyden M, Bronzwaer JG, Shah AM Paulus WJ (1999). Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation 99, 3009 3016. (Pubitemid 29270430)
20. Ikeda U, Maeda Y, Kawahara Y, Yokoyama M Shimada K (1995). Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. Circulation 92, 2683 2689.
21. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T Marumo F (1992). Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 19, 753 757.
22. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Murumo F Hiroe M (1993). endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 92, 398 403. (Pubitemid 23209021)
23. Just A, Olson AJ, Whitten CL Arendshorst WJ (2007). Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide. Am J Physiol Heart Circ Physiol 292, H83 H92. (Pubitemid 46105165)
24. Kass DA, Bronzwaer JG Paulus WJ (2004). What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 94, 1533 1542. (Pubitemid 38856960)
25. Kifor I Dzau VJ (1987). Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins. Circ Res 60, 422 428. (Pubitemid 17094121)
26. Kim S Iwao H (2000). Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52, 11 34. (Pubitemid 30127593)
27. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K Iwao H (1995). Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension 25, 1252 1259.
28. Kimbrough HM Jr., Vaughan ED Jr., Carey RM Ayers CR (1977). Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ Res 40, 174 178. (Pubitemid 8043438)
29. Kojda G, Kottenberg K, Nix P, Schluter KD, Piper HM Noack E (1996). Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 78, 91 101. (Pubitemid 26004125)
30. Kurisu S, Ozono R, Oshima T, Kambe M, Ishida T, Sugino H, Matsuura H, Chayama K, Teranishi Y, Iba O, Amano K Matsubara H (2003). Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension 41, 99 107. (Pubitemid 36056799)
31. Ladeiras-Lopes R, Ferreira-Martins J Leite-Moreira AF (2009). Acute neurohumoral modulation of diastolic function. Peptides 30, 419 425.
32. Layland J, Li JM Shah AM (2002). Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol 540, 457 467. (Pubitemid 35190124)
33. B receptor stimulation and their modulation by endocardial endothelium, NO, and prostaglandins. Am J Physiol Heart Circ Physiol 287, H1194 H1199. (Pubitemid 39096666)
34. + exchanger-mediated effect. Am J Physiol Heart Circ Physiol 284, H1332 H1339. (Pubitemid 36348597)
35. + exchanger-mediated effect. Br J Pharmacol 147, 690 697.
36. Levens NR, Freedlender AE, Peach MJ Carey RM (1983). Control of renal function by intrarenal angiotensin II. Endocrinology 112, 43 49.
37. Levens NR, Peach MJ Carey RM (1981). Role of the intrarenal renin-angiotensin system in the control of renal function. Circ Res 48, 157 167. (Pubitemid 11191027)
38. McClellan G, Weisberg A, Rose D Winegrad S (1994). Endothelial cell storage and release of endothelin as a cardioregulatory mechanism. Circ Res 75, 85 96. (Pubitemid 24187739)
39. McElmurray JH 3rd., Mukherjee R, New RB, Sampson AC, King MK, Hendrick JW, Goldberg A, Peterson TJ, Hallak H, Zile MR Spinale FG (1999). Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry. J Pharmacol Exp Ther 291, 799 811. (Pubitemid 29503556)
40. Mebazaa A, Mayoux E, Maeda K, Martin LD, Lakatta EG, Robotham JL Shah AM (1993). Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin. Am J Physiol Heart Circ Physiol 265, H1841 H1846. (Pubitemid 2014879)
41. Mohan P, Brutsaert DL, Paulus WJ Sys SU (1996). Myocardial contractile response to nitric oxide and cGMP. Circulation 93, 1223 1229. (Pubitemid 26087026)
42. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K Munzel T (2002). Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90, E58 E65. (Pubitemid 34163412)
43. A-receptor antagonist. Circulation 96, 1593 1597. (Pubitemid 27375357)
44. Mulrow PJ Franco-Saenz R (1996). The adrenal renin-angiotensin system: a local hormonal regulator of aldosterone production. J Hypertens 14, 173 176. (Pubitemid 26121858)
45. Paul M, Poyan Mehr A Kreutz R (2006). Physiology of local renin-angiotensin systems. Physiol Rev 86, 747 803. (Pubitemid 44033382)
46. Paulus WJ, Vantrimpont PJ Shah AM (1994). Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89, 2070 2078. (Pubitemid 24142783)
47. Pueyo ME, Arnal JF, Rami J Michel JB (1998). Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol Cell Physiol 274, C214 C220. (Pubitemid 28099361)
48. Re R (1987). The myocardial intracellular renin-angiotensin system. Am J Cardiol 59, 56A 58A. (Pubitemid 17023339)
49. Re R, Fallon JT, Dzau V, Ouay SC Haber E (1982). Renin synthesis by canine aortic smooth muscle cells in culture. Life Sci 30, 99 106. (Pubitemid 12188608)
50. Riggleman A, Harvey J Baylis C (2001). Endothelin mediates some of the renal actions of acutely administered angiotensin II. Hypertension 38, 105 109. (Pubitemid 34224780)
51. Rossi GP, Sacchetto A, Cesari M Pessina AC (1999). Interactions between endothelin-1 and the renin-angiotensin-aldosterone system. Cardiovasc Res 43, 300 307. (Pubitemid 29356368)
52. Sarkar D, Vallance P, Amirmansour C Harding SE (2000). Positive inotropic effects of NO donors in isolated guinea-pig and human cardiomyocytes independent of NO species and cyclic nucleotides. Cardiovasc Res 48, 430 439.
53. Schluter KD Wenzel S (2008). Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks. Pharmacol Ther 119, 311 325.
54. Serneri GG, Boddi M, Cecioni I, Vanni S, Coppo M, Papa ML, Bandinelli B, Bertolozzi I, Polidori G, Toscano T, Maccherini M Modesti PA (2001). Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res 88, 961 968. (Pubitemid 32441476)
55. Seyedi N, Xu X, Nasjletti A Hintze TH (1995). Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 26, 164 170.
56. Shah AM MacCarthy PA (2000). Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther 86, 49 86. (Pubitemid 30173144)
57. 2+ in intact cardiac myocytes. Circ Res 74, 970 978. (Pubitemid 24121601)
58. Southan GJ Szabo C (1996). Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 51, 383 394. (Pubitemid 26071171)
59. Suzuki H, Eguchi K, Ohtsu H, Higuchi S, Dhobale S, Frank GD, Motley ED Eguchi S (2006). Activation of endothelial nitric oxide synthase by the angiotensin II type 1 receptor. Endocrinology 147, 5914 5920.
60. Toda N, Ayajiki K Okamura T (2007). Interaction of endothelial nitric oxide and angiotensin in the circulation. Pharmacol Rev 59, 54 87. (Pubitemid 46333996)
61. Touyz RM Schiffrin EL (2000). Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52, 639 672.
62. Vila-Petroff MG, Younes A, Egan J, Lakatta EG Sollott SJ (1999). Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 84, 1020 1031. (Pubitemid 29227681)
63. Weber KT, Sun Y Campbell SE (1995). Structural remodelling of the heart by fibrous tissue: role of circulating hormones and locally produced peptides. Eur Heart J 16 (Suppl N 12 18. (Pubitemid 26082316)
64. Wollert KC Drexler H (1999). The renin-angiotensin system and experimental heart failure. Cardiovasc Res 43, 838 849. (Pubitemid 29413183)